<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02300454</url>
  </required_header>
  <id_info>
    <org_study_id>MEC2014-14</org_study_id>
    <nct_id>NCT02300454</nct_id>
  </id_info>
  <brief_title>Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions</brief_title>
  <acronym>ELEGANT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Mitsui Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Teikyo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tokai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mitsui Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of SeQuent® Please drug coated balloon (DCB) is effective to treat patients with in-stent
      restenosis (ISR). However, whether the type of pre-dilatation balloon prior to DCB dilatation
      impacts on clinical and angiographic outcomes or not is unknown. Lacrosse® Non-slip element
      balloon (NSE) is a balloon catheter with 3 longitudinal plastic elements which are attached
      to proximal and distal balloon edges. NSE is developed to incise neointimal tissue and avoid
      balloon slippage without vitiating balloon derivability and crossability. We investigated
      angiographic and clinical outcomes following normal non-compliant balloon or NSE dilatation
      prior to DCB dilatation in ISR lesions.This study is a single blinded, multicenter,
      randomized trial. Total 200 patients with ISR are randomly assigned to treat with
      non-compliant balloon or NSE before DCB dilatation. Optical coherence tomographic (OCT)
      analysis are performed before pre-dilatation and after DCB dilatation Follow-up angiography
      analysis are planned at 8 months in all patients. Clinical follow-up is planned at 8 and 24
      months.Primary endpoint is angiographic in-segment late loss at 8 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>angiographic minimal lumen diameter</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>minimal lumen area (OCT analysis)</measure>
    <time_frame>within one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean neointimal area (OCT analysis)</measure>
    <time_frame>within one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>angiographic acute gain</measure>
    <time_frame>within one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure</measure>
    <time_frame>8 months and 24 months</time_frame>
    <description>cardiac death, myocardial infarction, target vessel revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the prevalence of stent implantation</measure>
    <time_frame>within one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the prevalence of balloon slipping</measure>
    <time_frame>within one day</time_frame>
    <description>more than 3 mm balloon slipping</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DCB length</measure>
    <time_frame>within one day</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
    <description>subanalysis: drug eluting stent restenosis</description>
  </other_outcome>
  <other_outcome>
    <measure>angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
    <description>subanalysis: slipping group</description>
  </other_outcome>
  <other_outcome>
    <measure>angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
    <description>subanalysis: diffuse, occlusive, and proliferative restenosis type</description>
  </other_outcome>
  <other_outcome>
    <measure>angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
    <description>subanalysis: in-stent re-restenosis lesion</description>
  </other_outcome>
  <other_outcome>
    <measure>angiographic in-segment late loss</measure>
    <time_frame>8 months</time_frame>
    <description>subanalysis: stent diameter 2.25 or 2.5 mm</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Coronary Restenosis</condition>
  <arm_group>
    <arm_group_label>Non-slip element balloon (NSE)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lacrosse® NSE dilatation before use of SeQuent® Please drug coated balloon (DCB)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balloon</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-compliant balloon dilatation before use of SeQuent® Please drug coated balloon (DCB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-slip element balloon (NSE)</intervention_name>
    <description>Lacrosse® NSE and SeQuent® Please drug coated balloon (DCB)</description>
    <arm_group_label>Non-slip element balloon (NSE)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon</intervention_name>
    <description>Non-compliant balloon and SeQuent® Please drug coated balloon (DCB)</description>
    <arm_group_label>Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with in-stent restenosis lesions who are planned to be treated with drug
             coating balloon

        Exclusion Criteria:

          -  ST elevation myocardial infarction

          -  stent thrombosis

          -  severe renal dysfunction (eGFR &lt;30 ml/min) except dialysis

          -  pregnancy

          -  planned surgery within 3 months

          -  shock vital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ai Teramoto</last_name>
    <role>Study Director</role>
    <affiliation>Teikyo Academic Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tokai University</name>
      <address>
        <city>Isehara</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mitsui Memorial Hospital</name>
      <address>
        <city>Chiyoda-Ku</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2014</study_first_posted>
  <last_update_submitted>March 22, 2017</last_update_submitted>
  <last_update_submitted_qc>March 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mitsui Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Jiro Aoki</investigator_full_name>
    <investigator_title>Associate Director, Division of Cardiology</investigator_title>
  </responsible_party>
  <keyword>in-stent restenosis</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Restenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

